Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RPRX
#485
Royalty Pharma plc - Class A Ordinary Shares
61.9
2
USD
0.00%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.19%
Monthly Change
+3.36%
6 month change
+34.99%
Year Change
+66.18%
Previous Close
61.8
0
Open
61.9
2
Low
61.9
2
High
61.9
2
Volume
170
Markets
US Stock Market
Healthcare
Biotechnology
RPRX
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
388.13 M
432.96 M
443.17 M
446.69 M
433.32 M
428.42 M
575 M
Valuation ratios
Enterprise value
29.42 B
27.35 B
26.83 B
21.89 B
21.17 B
27.8 B
38.91 B
Price to earnings ratio
37.92
26.74
394
11.17
13.36
21.71
33.3
Price to sales ratio
8.85
7.22
7.71
7.24
6.7
9.17
13.74
Price to cash flow ratio
9.24
8.19
8.05
5.7
5.47
8.76
11.71
Price to book ratio
6.31
4.19
3.07
2.61
2.18
3.37
1.31
Enterprise value to EBITDA ratio
18.05
18.56
80.3
14.47
16.14
17.53
25.31
Profitability ratios
Return on assets %
0.06
0.04
0
0.07
0.05
0.04
0
Return on equity %
0.1
0.06
0
0.11
0.08
0.08
0
Return on invested capital %
45.75
39.11
7.99
38.15
30.83
32.89
2.79
Gross margin %
92.64
100.56
68.24
75.24
63.21
111.34
61.39
Operating margin %
75.17
62.49
13.73
63.37
57.1
65.58
19.75
EBITDA margin %
76.81
64.38
14.93
64.24
57.96
66.68
20.8
Net margin %
45.94
27.07
1.91
48.2
37.95
32.42
2.65
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
8.76
16.81
2.19
7.9
1.44
2.4
2.8
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.13
0.14
0.13
0.14
0.13
0.12
0.03
Solvency ratios
Debt to assets ratio
0.36
0.41
0.36
0.37
0.36
0.44
0.45
Debt to equity ratio
1.21
1.23
1.26
0.94
1.1
1.32
1.31
Long term debt to total assets ratio
—
0.41
0.42
0.37
0.42
0.46
0.45
Long term debt to total equity ratio
—
1.23
1.26
0.94
1.1
1.38
1.31
Per share metrics
Operating cash flow per share
5.42
4.86
4.9
4.96
4.66
4.41
5.32
EBIT per share
2.63
2.36
0.7
2.47
2.18
2.76
2.7
EBITDA per share
2.69
2.43
0.76
2.51
2.21
2.81
2.75
Total debt per share
9.58
11.69
16.25
10.18
12.81
15.18
16.09
Cash per share
3.4
3.61
3.96
0.82
1.66
1.13
1.5
Net current asset value per share
7.18
6.94
5.83
2.11
3.03
2.71
3.17
Tangible book value per share
12.76
13.91
12.85
10.83
11.69
9.84
10.61
Working capital per share
6.36
6.53
3.17
1.85
0.92
1.58
2.04
Book value per share
7.94
9.51
12.85
10.83
11.69
11.47
12.27
News
Royalty Pharma: Strong Execution, Higher Guidance, And Room For A Re-Rating (NASDAQ:RPRX)
Royalty Pharma Stock: The Quiet Compounder The Market Is Still Mispricing (NASDAQ:RPRX)
Royalty Pharma (RPRX) Crossed Above the 20-Day Moving Average: What That Means for Investors
Royalty Pharma (RPRX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Royalty Pharma (RPRX) Tops Q2 Earnings and Revenue Estimates
Royalty Pharma: At The Right P/E, I'm In (But Not Here) (NASDAQ:RPRX)
Gear Up for Royalty Pharma (RPRX) Q2 Earnings: Wall Street Estimates for Key Metrics
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Will Iovance Biotherapeutics (IOVA) Report Negative Q2 Earnings? What You Should Know
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
Royalty Pharma (RPRX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Bank of America Pops To New High, Leads 17 Newcomers To IBD 50, Other Top Stock lists